ArticleThe Lancet. Oncology2022

Residual cancer burden after neoadjuvant chemotherapy and long-term survival outcomes in breast cancer: a multicentre pooled analysis of 5161 patients.

Christina Yau et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.